Euroapi S.A. (EPA:EAPI)

Market Cap	297.87M
Revenue (ttm)	919.20M
Net Income (ttm)	-130.60M
Shares Out	95.23M
EPS (ttm)	-1.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	121,752
Average Volume	98,638
Open	3.126
Previous Close	3.128
Day's Range	3.106 - 3.220
52-Week Range	2.260 - 4.540
Beta	0.65
RSI	70.73
Earnings Date	Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. It offers their products to pharmaceutical, generic drug manufactu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,187
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.